Cranberry
Nutrition tradition
A tart red bog berry that became the world's best-known natural remedy for urinary infections - and one of the few plants where a regulator actually lets us say 'helps prevent.' Here's the honest version: who the research says it works for, who it doesn't, why it can never treat an infection you already have, and how to work out whether the product in your hand contains a dose worth taking. No hype, no BS.
In one minute
Cranberry is about preventing UTIs from coming back - it is not a treatment for an infection you already have, and treating one yourself by delaying antibiotics is genuinely risky.
The active measure is PACs (proanthocyanidins), which make it harder for E. coli to grip the bladder wall so urine can flush them out.
The 2023 Cochrane review (50 trials, 8,857 people) found a real benefit in women with recurrent UTIs, in children, and in people at risk after a bladder procedure.
The same review found no benefit in elderly people in institutional care, in pregnancy, or in adults who cannot empty their bladder fully.
36 mg of PACs a day is the figure the anti-adhesion research and French/European regulators converged on - with a 10% PAC extract that is 360 mg of powder.
Real cautions: warfarin, a history of kidney stones (cranberry is high in oxalate), and aspirin or salicylate sensitivity.
At a glance
History & natural history
Cranberry is one of the very few commercial fruits native to North America, and its story is a bog story before it is a medicine story.
Where it grows, and the flooded fields
Vaccinium macrocarpon is a low, trailing evergreen vine that grows in acidic peat bogs and wetlands across the northeastern and north-central parts of the continent. The vines are perennial and remarkably long-lived - some commercial beds have been producing for over a century. The famous images of workers wading through crimson lakes are a harvesting technique, not how the berries grow: growers flood the bed, machines dislodge the fruit, and because each berry contains four small air chambers, they float to the surface to be corralled and skimmed off. Dry-harvested berries, picked with mechanical rakes, are the ones sold fresh.
Indigenous use
Long before commercial cultivation, cranberries were food, dye and medicine across their native range. NCCIH's account is that cranberry 'has a history of traditional use in dyes, food, and medicine among Native Americans and later European settlers,' with the fruits and leaves thought to act on disorders of the bladder, stomach, blood and liver, and on wounds, diabetes and scurvy. The berry's natural acidity and preservative qualities made it valuable well beyond medicine - it keeps for months.
The scurvy connection and the ships
Because cranberries store well and are reasonably high in vitamin C, they travelled. New England sailors carried barrels of them, and the anti-scurvy reputation followed the fruit into European medical writing. It is a smaller story than the lime, but a real one.
From folk remedy to laboratory
The modern scientific era begins in the mid-twentieth century with the acidification theory - the idea that cranberry worked by making urine hostile through hippuric acid. The earliest study in Health Canada's own reference list for cranberry is Bodel and colleagues, 1959, on exactly that question. That explanation held for decades before it was overturned. Beginning in the late 1980s and accelerating through the 1990s, researchers established that cranberry's real trick was anti-adhesion, and by 2000 Foo, Howell and colleagues had identified the specific culprits: A-type proanthocyanidin trimers that block uropathogenic E. coli from gripping bladder cells. That structural discovery is what turned cranberry from a folk remedy into a standardizable ingredient - because once you know which molecule matters, you can measure it.
Where the evidence sits now
The formal assessment began in 1998 with the first Cochrane review on cranberry and UTIs. It has been updated five times since, most recently in November 2023, growing from a handful of small trials to 50 studies and 8,857 participants. Few plant medicines have been examined that persistently - and the current answer, that it helps some populations meaningfully and others not at all, is more useful than the simple yes or no people usually want.
The science, graded honestly
We grade the evidence for every use so you can see the difference between "proven," "promising," and "traditional."
Most urinary infections start the same way. E. coli bacteria from the gut reach the urethra, travel up to the bladder, and then - the critical step - grip onto the cells lining the bladder wall using tiny hair-like hooks called P-fimbriae. If they cannot grip, the flow of urine simply flushes them out before they can multiply.
Cranberry's proanthocyanidins interfere with that grip. Cranberry PACs are chemically unusual: they contain what chemists call A-type linkages, a structural quirk that the PACs in grape seed, cocoa and apple mostly lack, and it is the A-type structure that is credited with the anti-adhesion effect. Memorial Sloan Kettering's herb monograph puts it exactly this way - the A-type linkages 'may enhance urinary bacterial antiadhesion activities to prevent UTIs.'
## Why that makes it a preventive, not a cure
Read the mechanism again and the limit is obvious. Anti-adhesion acts on bacteria that have not settled in yet. Once an infection is established - bacteria multiplying, burning, urgency, pain - making the bladder surface slippery does nothing about the colony already there. That is what antibiotics are for. This is not a hedge for legal reasons; it is what the biology predicts, and it is why the NIH's NCCIH states plainly that cranberry 'isn't recommended as a treatment for existing UTIs in any population.'
## It wears off, which is why it has to be daily
The anti-adhesion effect is temporary. In the studies France's food safety agency reviewed, anti-adhesion activity in urine peaked around six hours after a dose and had faded by twenty-four. Cranberry is therefore a maintained condition, not an event - a daily habit, judged over months.
## The old theory, and why it was replaced
For most of the twentieth century the explanation was different: cranberry was thought to work by acidifying urine, an idea traceable to work on hippuric acid in the 1950s. Cranberry does lower urinary pH, but the acidification is too modest to be antibacterial on its own. The anti-adhesion model replaced it, and it is the one all of today's dosing and standardization is built on.
Urinary tract health
Reasonably supportedThis is the claim cranberry is sold on, and it is the one with real evidence behind it - so it is worth understanding how that evidence was assembled rather than just what it found. The key document is the 2023 Cochrane review by Williams and colleagues, published 10 November 2023. Cochrane reviews do not run new experiments. They hunt down every randomised trial ever done on a question, judge how well each one was conducted, and pool the results using a formal grading system. This one searched the literature up to 13 March 2023 and ended up with 50 randomised trials covering 8,857 people - the fifth update of a review first published back in 1998, with 26 new studies added in this round alone.
Pooling every trial that could be meaningfully combined, cranberry products reduced the risk of symptomatic, culture-verified UTIs by about 30% (6,211 participants, risk ratio 0.70, 95% confidence interval 0.58 to 0.84). Cochrane rated that moderate-certainty evidence, which is about as good as plant-medicine evidence gets. Narrowed to the group most people reading this belong to - women with recurrent UTIs - it was eight trials and 1,555 women, with roughly a 26% reduction (RR 0.74, 95% CI 0.55 to 0.99).
Two honest caveats about that number, because they matter. First, the confidence interval nearly touches 1.0, which in plain English means the true benefit could be quite small. Second, the trials varied considerably in their results (I-squared 54%), which usually signals that the products, doses and populations were not really comparable to each other - unsurprising when nobody was measuring PAC content consistently. 'Culture-verified' is worth noticing too: these were real infections confirmed in a lab, not just people reporting that they felt better.
So what should you take from it? A real, repeatedly observed, moderate reduction in how often infections come back. Not a guarantee, and not a large effect. NCCIH summarises the same body of work as roughly a 25% reduction in symptomatic recurrent UTIs in women, 'in some cases, by more than 30 percent,' while noting that inconsistent findings keep the question open. Health Canada takes a more permissive position than most regulators and allows licensed cranberry products to say 'Helps prevent (recurrent) urinary tract infections (UTIs) (in women)' - one of the few plant claims where a Canadian regulator has gone beyond 'traditionally used.'
Williams et al., Cochrane Database Syst Rev 2023;11:CD001321 ↗Urinary tract health (children)
Reasonably supportedThis is the subgroup that surprises people, because it is where the 2023 Cochrane review found its largest and most consistent effect. Five randomised trials covering 504 children were pooled, and cranberry products roughly halved the risk of symptomatic, culture-verified UTIs (risk ratio 0.46, 95% confidence interval 0.32 to 0.68). Just as importantly, the trials largely agreed with each other - the heterogeneity statistic was low (I-squared 21%), which means the five studies were telling a similar story rather than pulling in opposite directions. That consistency is often more reassuring than the size of an effect.
The caveats are the obvious ones. Five hundred children spread across five trials is not a large body of evidence, the products and doses differed, and children's cranberry doses were not standardized to PAC content any more than adults' were. And there is a clinical point that matters more than the statistics: repeated urinary infections in a child are frequently a sign of something anatomical or functional - reflux, incomplete emptying, constipation - that needs a paediatric assessment. Cranberry does not investigate anything. It should sit alongside proper medical care, never in place of it.
One practical safety note specific to this group: NCCIH observes that cranberry in very large amounts can cause stomach upset and diarrhoea, 'particularly in young children.' Small, consistent daily amounts are the sensible approach, and the dose for a child is a conversation for a paediatrician.
Williams et al., Cochrane Database Syst Rev 2023;11:CD001321 ↗Post-procedure urinary support
Reasonably supportedThis is the quietest of cranberry's three positive findings and arguably the cleanest. The 2023 Cochrane review pooled six randomised trials covering 1,434 people who had become susceptible to UTIs because of an intervention involving the bladder - bladder radiotherapy being the clearest example. Cranberry products cut the risk of symptomatic, culture-verified UTIs by more than half (risk ratio 0.47, 95% confidence interval 0.37 to 0.61).
What makes this result stand out is the agreement between the trials. The heterogeneity statistic was zero (I-squared 0%), meaning the six studies produced results so consistent with one another that the variation could be explained by chance alone. That is unusual in botanical research, where trials of the same herb routinely contradict each other, and it is a stronger signal of a genuine effect than a big number from studies that disagree.
The honest limits: 1,434 people across six trials is still a modest evidence base, 'an intervention involving the bladder' covers a range of quite different clinical situations, and the trials were not standardized to a common PAC dose. Nor does this tell you anything about catheter-associated infections in people with long-term indwelling catheters, which is a different problem with different evidence. But if you are heading into a bladder procedure and asking whether cranberry is worth mentioning to your specialist, the answer is that the evidence here is more consistent than in almost any other cranberry population.
Worth noting on the regulatory side: Health Canada's permitted claim wording is written specifically for women and recurrent UTIs, so this finding sits outside what any Canadian label may say. We are describing published research, not a licensed claim.
Williams et al., Cochrane Database Syst Rev 2023;11:CD001321 ↗Antioxidant status
Well establishedThis is the least glamorous claim on the page and the most solidly settled. Health Canada's cranberry monograph permits two antioxidant statements outright: 'Source of antioxidants / Provides antioxidants,' and the longer form, 'Provides antioxidants that help fight and protect cells against the oxidative damage caused by free radicals.' It cites human and compositional work including a placebo-controlled pilot in healthy women by Valentenova and colleagues (2007), a short-term juice study in men by Ruel and colleagues (2005), and the American Herbal Pharmacopoeia's cranberry compendium.
It helps to be precise about what this kind of claim actually is. 'Source of antioxidants' is largely a statement about what is in the food, backed by measurements of plasma antioxidant capacity after people consume it. It is not a claim that you will get fewer illnesses, and no regulator is saying it is. Cranberry genuinely is one of the richer common fruits in polyphenols; that is a real fact about the berry, and a modest one about your health.
Health Canada's dose ceilings for the antioxidant use are lower than for the UTI use, which is worth knowing if you are comparing labels: not to exceed 30 grams of fresh fruit per day (roughly 4-5 g of dried fruit), or not to exceed 950 millilitres of juice per day, for adults 18 and over. Unlike the UTI indication, no minimum duration statement is required.
One practical note. Because 'antioxidant' is the easiest claim to get approved, it is also the one you will see plastered across cranberry products that contain almost no meaningful PAC content. A product can be a perfectly legitimate source of antioxidants and still be useless for the urinary-tract reason you bought it. The antioxidant claim tells you nothing about PAC dose.
Health Canada NHPID Monograph: Cranberry (27 March 2026) ↗Mechanism and dosing
Reasonably supportedIf you have ever wondered where the number 36 came from, this is the answer. In 2004 France's food safety agency, AFSSA, issued a positive opinion accepting the wording 'Helps to reduce the adherence of certain E. coli bacteria to the urinary tract walls' - on the basis of studies conducted with cranberry products providing 36 mg of proanthocyanidins per day. That figure has anchored the global cranberry supplement market ever since. It is documented in ANSES Opinion 2010-SA-0214, which reviews the whole file in English.
The experiments behind it work in an unusual and rather elegant way. Researchers give volunteers a known PAC dose, collect their urine hours later, and then pour that urine over bladder cell lines in a dish along with P-fimbriated E. coli - counting how many bacteria manage to stick. In the multicentre trial by Howell and colleagues (2010), 32 healthy women took a cranberry extract standardized for PAC content at 0, 18, 36 or 72 mg per day in a randomised, double-blind crossover design with six-day washouts. The anti-adhesion effect was clearly dose-dependent. In urine collected six hours after the dose, 36 mg and 72 mg both beat 18 mg, with no meaningful difference between them; in urine collected at twenty-four hours, only 72 mg still stood apart. The effect peaked around six hours and had essentially gone by twenty-four - which is why daily dosing matters.
Now the limitation, and it is a real one. This is a laboratory surrogate. It measures bacterial stickiness in urine, not infections in people. When the 2023 Cochrane review looked at the clinical question directly, it reported that 'no difference in the risk for UTIs could be demonstrated between low, moderate and high doses of PACs,' and rated the evidence comparing PAC doses as very low certainty. So the honest reading is that 36 mg per day is a well-reasoned, widely adopted, mechanistically grounded target - not a proven clinical threshold, and not a cliff you fall off below.
France's own drug agency drew the conclusion that matters commercially. Writing in 2008, it acknowledged evidence of efficacy for preparations providing 36 mg PAC per day against E. coli, but declined to recommend cranberry generally, 'especially since the composition of the available preparations varies greatly.' That sentence is the entire case for buying a standardized, tested product rather than a bag of unmeasured cranberry powder.
ANSES Opinion, Request no. 2010-SA-0214 ↗Traditional and historical use
Traditional useCranberry's medicinal reputation is genuinely old and genuinely North American, which is rarer than it sounds - most of the plants in a Western supplement aisle arrived via European or Asian herbal traditions. NCCIH's fact sheet summarises the record: cranberry 'has a history of traditional use in dyes, food, and medicine among Native Americans and later European settlers,' and 'cranberry fruits and leaves were thought to have therapeutic effects on disorders of the bladder, stomach, blood, and liver, and on various conditions like wounds, diabetes, and scurvy.' The bladder association, in other words, is not a modern marketing invention. It predates the science by centuries.
Health Canada recognises this history explicitly. Its monograph permits the traditional wording '(Traditionally) used in Herbal Medicine to help prevent (recurrent) urinary tract infections (UTIs) (in women)' as a separate, parallel option to the modern evidence-based claim - and it requires that if a multi-ingredient product mixes traditional and modern claims, the traditional claim must name the specific ingredient and the tradition it comes from.
The bridge between folklore and laboratory is documented too. The earliest study in Health Canada's own reference list is Bodel and colleagues (1959) on cranberry juice and the antibacterial action of hippuric acid - the urine-acidification theory that dominated thinking for decades before the anti-adhesion model replaced it. It is a good reminder that traditional use can point at a real effect while getting the explanation entirely wrong.
What we will not do is dress the tradition up. There is no evidence that cranberry was a rare or ceremonial medicine, and it was not 'nature's antibiotic.' It was a common, tart, useful berry that people ate, preserved, dyed cloth with, and reached for when their bladder hurt.
NCCIH: Cranberry ↗Who it helps - and who it doesn't
The 2023 Cochrane review is the single most useful document on this subject, and its most valuable feature is not the headline number - it is that the authors split the results by population. Cranberry is not equally useful for everyone at risk of a UTI, and the differences are large enough to change whether it is worth your money.
Where the evidence supports it
Women with recurrent UTIs. Eight trials, 1,555 women: about a 26% reduction in symptomatic, culture-confirmed UTIs (risk ratio 0.74, 95% confidence interval 0.55 to 0.99). Note how close that upper bound sits to 1.0 - the benefit is real but modest, and the trials disagreed with one another more than you would like.
Children. Five trials, 504 children: a larger effect (RR 0.46, 95% CI 0.32 to 0.68), and the trials agreed with each other reasonably well.
People made vulnerable by a procedure - for example bladder radiotherapy or a urological intervention. Six trials, 1,434 people (RR 0.47, 95% CI 0.37 to 0.61), with essentially no disagreement between trials.
Where it does not appear to help
Older people living in institutions. Three trials, 1,489 people: no benefit (RR 0.93, 95% CI 0.67 to 1.30), rated moderate certainty.
Pregnancy. Three trials, 765 women: no benefit (RR 1.06, 95% CI 0.75 to 1.50). Pregnant women should be discussing UTIs with their care team regardless - untreated ones matter more in pregnancy, not less.
Adults with neuromuscular bladder dysfunction who cannot empty fully. Three trials, 464 people: no benefit (RR 0.97, 95% CI 0.78 to 1.19), low certainty.
The pattern, said honestly
Cranberry seems to help where the problem is bacteria arriving and sticking. It does not help where the underlying problem is something else - urine sitting in a bladder that will not drain, or the tangled realities of frail institutional care. If you are in one of those second groups, the honest answer is that cranberry is probably not your answer, and the conversation to have is with a doctor about what is actually driving the infections.
Juice, capsules, extract, antibiotics, D-mannose
Cranberry juice cocktail versus cranberry the ingredient
The cranberry most people have actually consumed is 'cranberry juice cocktail' - a modest fraction of real juice, the rest water and a large quantity of added sugar, because pure cranberry juice is close to undrinkable. Reaching a research-grade PAC intake that way means a lot of liquid and a lot of sugar. It is not that juice cannot work; several trials in the Cochrane review used juice. It is that sweetened cocktail is a poor, expensive and unmeasurable way to deliver the compound you are actually after.
Juice versus tablets versus standardized extract
Cochrane looked at this directly and came back honest: it is 'unclear whether efficacy differs between cranberry juice and tablets,' because the certainty of that evidence was very low. So nobody can tell you with confidence that a capsule beats a glass. What is clearer, and what NCCIH flags explicitly, is that processing cranberries into tablets or capsules can reduce PAC concentration - which is why the number on the label matters more than the format.
Cranberry versus antibiotics
In the two trials that compared them head to head for prevention (385 participants), cranberry products may make little or no difference to the risk of symptomatic, culture-verified UTIs (RR 1.03, 95% CI 0.80 to 1.33). That is a genuinely interesting finding for anyone trying to reduce long-term prophylactic antibiotic use. It is also underpowered, and it is a conversation to have with a prescriber - never a reason to stop a prescription on your own.
Cranberry versus probiotics
Three small trials, 215 participants: cranberry may reduce the risk of symptomatic, culture-verified UTIs compared with probiotics (RR 0.39, 95% CI 0.27 to 0.56). Small numbers, but pointing in cranberry's favour.
Cranberry and D-mannose
These are often sold together and often confused. They are different molecules approaching the same problem from different angles - D-mannose is a simple sugar thought to occupy bacterial binding sites, while cranberry PACs act on the fimbriae themselves. Health Canada's cranberry monograph says nothing about D-mannose, and we are not making a claim about the combination. We are only noting that they are not the same thing, and buying one is not buying the other.
Notes for practitioners
Health Canada's cranberry monograph (Vaccinium macrocarpon, fruit; most recently updated 27 March 2026) is unusually permissive by international standards. It allows both a traditional-use claim and a non-traditional claim - 'Helps prevent (recurrent) urinary tract infections (UTIs) (in women)' - alongside two antioxidant claims. The subpopulation is adults 18 years and older.
Dosing is expressed in plant material, not PACs
For the recurrent-UTI indication: 10-30 g of fresh fruit per day (approximately 1.5-5 g dried fruit), or 90-950 mL of juice per day. For the antioxidant indication: not to exceed 30 g of fresh fruit per day (approximately 4-5 g dried), or not to exceed 950 mL of juice per day. Duration of use for the UTI indication carries a required statement: use for at least 4 weeks to see beneficial effects.
This matters when advising on products. The monograph's compendial route covers fresh, dry, powdered and non-standardized extracts (ethanol/water solvents only) plus juice - so a PAC-standardized extract sits in a different regulatory conversation from a compendial fruit or juice product. The 36 mg PAC/day figure that dominates the commercial literature comes from AFSSA/ANSES and the anti-adhesion research, not from Health Canada.
Required label cautions
Three, all from the monograph: ask a practitioner before use with a history of kidney stones; ask a practitioner before use if taking blood thinners; and, for the UTI indication, ask a practitioner if symptoms persist or worsen.
Interactions worth knowing
Memorial Sloan Kettering's monograph is the most detailed accessible source. Warfarin data are conflicting, but there are several case reports of raised INR and two deaths from internal haemorrhage with concurrent use; MSK's practical position is that monitoring intake rather than blanket avoidance may be warranted, which is a prescriber's judgement, not a patient's. There is a case report of subtherapeutic tacrolimus in a renal transplant patient after cranberry extract, resolving on cessation. Cranberry inhibits enteric CYP3A and modulates UGT enzymes in vitro. Cranberry also acidifies urine, which MSK notes increases uric acid stone risk, and increases urinary oxalate excretion.
One point for antibiotic stewardship conversations
In the 2023 Cochrane review, cranberry was roughly comparable to antibiotics in the two head-to-head prophylaxis trials (385 participants, RR 1.03, 95% CI 0.80 to 1.33). Underpowered and not a basis for substitution - but relevant when a patient is weighing months of prophylactic antibiotics.
— Health Canada NHPID Monograph: Cranberry
What we're actually allowed to say
Myth or fact?
Tap each one to see the verdict.
No - and this is the one item on this page we would ask you to take seriously, because believing it can genuinely hurt you. Cranberry's mechanism is anti-adhesion: it makes it harder for bacteria to grip the bladder wall. That does nothing about a colony that has already established itself and is multiplying. The NIH's NCCIH states it flatly: while cranberry may help prevent symptomatic UTIs in some women, 'it isn't recommended as a treatment for existing UTIs in any population,' and 'people who think they have a UTI should see a health care provider for diagnosis and treatment.' The real danger is not that cranberry fails - it is the days lost while you wait for it to work. An untreated bladder infection can travel up to the kidneys, which is a serious illness. Burning, urgency, cloudy or bloody urine, fever, chills or back pain mean call a doctor today, not open a supplement jar. Health Canada requires licensed cranberry products to carry the instruction to ask a health care practitioner if symptoms persist or worsen - that warning is on the label for exactly this reason. NCCIH: Cranberry ↗
Mostly myth, and it deserves a fair caveat first. Several of the trials in the 2023 Cochrane review used juice and found benefit, and Cochrane explicitly says it is 'unclear whether efficacy differs between cranberry juice and tablets,' because that comparison rests on very low certainty evidence. Nobody has proven the capsule beats the glass. The problem is what people actually drink. Cranberry juice cocktail - the standard supermarket product - is heavily diluted and heavily sweetened, because pure cranberry juice is far too tart for most palates. Reaching a research-level PAC intake that way means a great deal of sugar and a great deal of liquid. And crucially, a juice carton almost never states its PAC content, so you cannot know what you are getting. Cochrane names this as the field's central problem: there is 'no formal regulation by health authorities of cranberry products. In particular, the dose suggested may not be included on the package.' Unsweetened cranberry juice is a perfectly good food and a real source of PACs. It simply is not a measurable dose - and cranberry is an ingredient where the dose is the whole question. Cochrane 2023, CD001321 ↗
This was the accepted explanation for most of the twentieth century, and it is still repeated everywhere - but the science moved on. The idea traces back to work in the 1950s on cranberry, hippuric acid and urinary acidity, and it is even cited in Health Canada's own reference list. Cranberry does genuinely lower urinary pH; Memorial Sloan Kettering lists 'decreased urinary pH' as an observed effect. The trouble is that the change is far too small to be antibacterial on its own. The current model is anti-adhesion, and it is a different kind of explanation entirely: cranberry's A-type proanthocyanidins interfere with the P-fimbriae that E. coli use to grip the bladder lining, so the bacteria get flushed out rather than killed. That is what all the modern dosing research measures. There is a sting in the tail worth knowing. MSK notes that cranberry juice actually increases the risk of uric acid stone formation precisely because of that acidifying effect and its slowing of urate synthesis. So the acidification is real - it just survives as a side effect to be aware of, not as the reason cranberry works. MSK About Herbs: Cranberry ↗
It depends entirely on why you are prone to them, and the 2023 Cochrane review is unusually clear about this because the authors broke their results down by population rather than reporting a single average. Three groups where cranberry did not help: older people living in institutional care (3 trials, 1,489 people, risk ratio 0.93, 95% CI 0.67 to 1.30, moderate certainty); pregnant women (3 trials, 765 women, RR 1.06, 95% CI 0.75 to 1.50, moderate certainty); and adults with neuromuscular bladder dysfunction who cannot empty their bladder completely (3 trials, 464 people, RR 0.97, 95% CI 0.78 to 1.19). Cochrane's own conclusion states it directly: 'the evidence currently available does not support its use in the elderly, patients with bladder emptying problems, or pregnant women.' The logic behind the pattern makes sense. Cranberry addresses bacteria arriving and sticking. It does nothing about urine sitting in a bladder that will not drain, and it does not appear to overcome the complex mix of factors driving infections in frail institutional populations. If that is your situation, cranberry is very unlikely to be your answer - and the useful conversation is with a doctor about the underlying cause. Williams et al., Cochrane Database Syst Rev 2023;11:CD001321 ↗
Half right, and the half that is wrong is the half people spend money on. In the laboratory, dose-response is real. In the anti-adhesion studies reviewed by ANSES, urine collected after 72 mg of PACs showed a stronger and longer-lasting effect than 36 mg or 18 mg - at twenty-four hours only the 72 mg dose still stood apart. So more PAC does produce more measurable anti-adhesion activity in a dish. But when you count actual infections in actual people, that advantage disappears. The 2023 Cochrane review looked directly at trials comparing different PAC doses and reported that 'no difference in the risk for UTIs could be demonstrated between low, moderate and high doses of PACs,' rating the evidence very low certainty. It also found no clear relationship between how faithfully people took their cranberry and their risk of repeat UTIs. The practical reading: 36 mg a day is a sensible, well-grounded target rather than a floor to leap over. And there is a cost to going high - cranberry is rich in oxalate, and larger doses mean more of it, which matters a great deal if you form kidney stones. A product that tells you its PAC number honestly beats one that shouts a bigger one. Cochrane 2023, CD001321 ↗
How to use it
Common forms
How much
Cranberry is dosed in two completely different currencies, and knowing which one you're looking at is most of the battle. By PAC content - how the research and standardized extracts work. The daily amount the anti-adhesion studies converged on, and which French and European regulators accepted for an anti-adherence statement, is 36 mg of proanthocyanidins. With a 10% PAC extract that's 360 mg of powder: 10% means 100 mg of PACs per gram, so 36 divided by 100 is 0.36 g. Higher amounts (72 mg PAC) keep the effect running longer in laboratory tests, but the 2023 Cochrane review could demonstrate no difference in actual UTI rates between low, moderate and high PAC doses - so more is not demonstrably better, and it does mean more oxalate. By plant material - how Health Canada's monograph works. For the recurrent-UTI use, Health Canada sets 10-30 g of fresh fruit per day (roughly 1.5-5 g of dried fruit), or 90-950 mL of juice per day. For the antioxidant use the ceiling is 30 g of fresh fruit (about 4-5 g dried) or 950 mL of juice per day. Adults 18 years and older. Timing and duration. Take it daily. The anti-adhesion effect peaks around six hours after a dose and has faded by twenty-four, so consistency is the whole game - some people split it morning and evening. Health Canada's monograph requires the statement 'use for at least 4 weeks to see beneficial effects,' and realistically you should judge it over months, by counting infections, not by how you feel on any given day.
As unsweetened juice, or a PAC-standardized capsule.
Cranberry is the ingredient where labels most often hide the ball. Four checks before you buy:
Look for a PAC percentage, not just milligrams of cranberry. '500 mg cranberry' tells you nothing about actives. A product standardized to a stated PAC percentage does.
Do the arithmetic yourself. PAC percentage x milligrams per serving = milligrams of PACs. A 10% extract gives 100 mg of PACs per gram, so 360 mg of powder is 36 mg of PACs - the figure the anti-adhesion research and European regulators use.
Don't be fooled by a big extract ratio. '50:1 concentrate' is not a PAC number. If a seller won't state PAC content, assume nobody measured it - Cochrane's own summary warns that the dose 'may not be included on the package.'
Ask for the Certificate of Analysis. A real COA shows the PAC assay and heavy-metal testing. We publish ours on the product page; if a seller can't produce one, you have no way to verify any of the above.
Frequently asked questions
Straight answers to the things people actually ask.
Cranberry (Vaccinium macrocarpon) is a small, hard, intensely tart red berry native to North America, grown in bogs and harvested by flooding the fields so the berries float. Its medicinal reputation is genuinely old - NCCIH notes a history of use among Native Americans and later European settlers for disorders of the bladder, stomach, blood and liver, as well as for wounds and scurvy. Today it is used for one main purpose: reducing how often urinary tract infections come back in people who get them repeatedly. The compounds credited with that are proanthocyanidins, or PACs, which appear to stop E. coli bacteria from gripping the bladder wall. In Canada, Health Canada permits licensed cranberry products to say they help prevent recurrent UTIs in women, and to make antioxidant claims. It is a preventive, not a treatment.
It is real, and it is moderate. The best evidence is the 2023 Cochrane review by Williams and colleagues, which pooled 50 randomised trials covering 8,857 people. Across the trials that could be combined, cranberry reduced the risk of symptomatic, culture-verified UTIs by about 30% (risk ratio 0.70), rated moderate-certainty evidence. In women with recurrent UTIs specifically, it was eight trials and 1,555 women, with about a 26% reduction. NCCIH describes the same body of work as roughly a 25% reduction, sometimes more than 30%, while noting the findings are inconsistent. So: fewer infections, not no infections - and the effect is small enough that you would only notice it by counting over months, not by how you feel week to week.
No. Please see a doctor. Cranberry works by making it harder for bacteria to stick to the bladder wall, which does nothing about an infection that is already established and multiplying. NCCIH states that cranberry 'isn't recommended as a treatment for existing UTIs in any population' and that people who think they have a UTI should see a health care provider for diagnosis and treatment. The risk here is not that cranberry does nothing - it is the delay. An untreated bladder infection can move up to the kidneys, which is a much more serious illness. Burning, urgency, cloudy or bloody urine, fever, chills or back or flank pain all mean get care today. Health Canada requires licensed cranberry products to carry the instruction to ask a practitioner if symptoms persist or worsen, and that warning exists for exactly this reason.
The figure the research settled on is 36 mg of proanthocyanidins per day. It comes from the anti-adhesion studies reviewed by France's food safety agency: AFSSA accepted an anti-adherence statement on the basis of studies using cranberry products providing 36 mg PAC daily, and it is documented in ANSES Opinion 2010-SA-0214.
The arithmetic is easy once a product tells you its PAC percentage. Multiply the percentage by the milligrams per serving. A 10% PAC extract contains 100 mg of PACs per gram of powder, so 360 mg of powder gives you 36 mg of PACs. A 1% product would need 3.6 grams to reach the same place.
One honest caveat: 36 mg is a mechanistically grounded target, not a proven clinical cliff. The 2023 Cochrane review found that no difference in UTI risk could be demonstrated between low, moderate and high PAC doses, so treat 36 mg as a sensible aim rather than a magic number - and note that Health Canada does not set a PAC dose at all.
It can be, but the juice most people drink is not. Cranberry juice cocktail is mostly water and added sugar with a modest fraction of real juice, because pure cranberry juice is extremely tart. Getting a research-level PAC intake that way means a lot of liquid and a lot of sugar, and the carton will almost never tell you its PAC content - so you have no way to know what you are getting. Cochrane names this as the central problem in the whole field: cranberry products are not formally regulated for PAC content, and 'the dose suggested may not be included on the package.' To be fair, several trials in the Cochrane review did use juice and found benefit, and Cochrane says it is unclear whether juice and tablets differ in effectiveness. Unsweetened cranberry juice is a good food. It is just not a measurable dose, and NCCIH also points out that processing cranberries into tablets or capsules can itself reduce PAC concentration - which is why a stated, tested PAC number beats any format argument.
Health Canada's cranberry monograph requires the statement 'use for at least 4 weeks to see beneficial effects' for the recurrent-UTI indication, so four weeks is the minimum before you judge anything. Realistically you are measuring prevention, which means counting infections over several months and comparing with your usual pattern - there is no day-to-day feeling to track.
Timing within the day matters less than consistency. The anti-adhesion effect is temporary: in the studies ANSES reviewed, activity in urine peaked around six hours after a dose and had faded by twenty-four. That is the argument for taking it every single day rather than occasionally, and some people split the dose morning and evening for that reason. Take it with or without food, whichever helps you remember.
Four groups should check with a health professional first.
Anyone on warfarin or other blood thinners. Health Canada requires this warning on the label. The data are genuinely conflicting, but Memorial Sloan Kettering's monograph records several case reports of raised INR and two deaths from internal haemorrhage with concurrent warfarin and cranberry juice. Do not manage this yourself.
Anyone with a history of kidney stones. Also a required Health Canada warning. Cranberry is high in oxalate and increases urinary oxalate excretion, which can promote the most common kind of stone; MSK also notes its urine-acidifying effect raises uric acid stone risk, and cites a case of recurrent stones in a man taking cranberry concentrate tablets twice daily for six months.
Anyone sensitive to aspirin or salicylates. Cranberry naturally contains salicylates. In a controlled study published in the Journal of Agricultural and Food Chemistry, two weeks of daily cranberry juice significantly raised salicylic acid in volunteers' urine and plasma, though absorbed amounts remained low.
Anyone pregnant or breastfeeding, or on narrow-margin medication. NCCIH notes food amounts appear safe but evidence for larger supplemental amounts is not conclusive - and Cochrane found no UTI benefit in pregnancy anyway. MSK also reports a case of cranberry dropping tacrolimus to subtherapeutic levels, and notes cranberry affects CYP3A and UGT enzymes in lab studies.
For most people it is very well tolerated. The 2023 Cochrane review looked at this across 10 trials and 2,166 participants and concluded that gastrointestinal side effects probably do not differ between people taking cranberry products and those taking a placebo or nothing - moderate-certainty evidence. That is a reassuring finding from a large pool of trials.
The exception is quantity. Memorial Sloan Kettering notes that large amounts of cranberry juice - around three cups a day - have been associated with nausea, vomiting and diarrhoea, and NCCIH adds that young children are more susceptible to stomach upset from large amounts. Concentrated extract taken at a sensible dose is a very different proposition from litres of juice.
The more meaningful concerns are not side effects but interactions and predispositions: warfarin, kidney stones, and salicylate sensitivity. Those are covered in the safety section on this page.
More than for most plants, which is unusual and worth understanding. Health Canada's cranberry monograph (updated 27 March 2026) permits four uses on licensed products: 'Source of antioxidants'; the longer antioxidant wording about protecting cells against free radicals; '(Traditionally) used in Herbal Medicine to help prevent (recurrent) urinary tract infections (UTIs) (in women)'; and - importantly - the non-traditional, evidence-based claim 'Helps prevent (recurrent) urinary tract infections (UTIs) (in women).' That last one is rare. Most botanicals in Canada only get a 'traditionally used' framing.
The boundaries are firm, though. The permitted wording is prevention only, never treatment. It is written for women, adults 18 and over. Doses are set in fresh fruit, dried fruit and juice equivalents - 10 to 30 g of fresh fruit per day, or 90 to 950 mL of juice per day for the UTI use - and the monograph sets no PAC threshold at all, so the 36 mg figure you see everywhere is research context rather than a Canadian dose. Three cautions are required on-label: ask a practitioner if you have a history of kidney stones, ask if you take blood thinners, and ask if symptoms persist or worsen.
Our Cranberry Extract, and how to do the PAC maths
Cranberry is the ingredient where the word 'standardized' actually earns its keep, because PAC content varies enormously between products and most labels never tell you. Cochrane's own plain-language summary puts the problem bluntly: there is 'no established regimen for what PACs dose to use and no formal regulation by health authorities of cranberry products. In particular, the dose suggested may not be included on the package.' France's food safety agency reached a similar conclusion years earlier - the evidence for cranberry was real, but it declined to recommend it broadly 'especially since the composition of the available preparations varies greatly.'
That is precisely the gap standardization closes. Ecogenya's Cranberry Extract is standardized to 10% proanthocyanidins. That single number is what makes the arithmetic possible, and the arithmetic is simple enough to do in your head.
## The maths
- 10% PAC means 100 mg of PACs in every 1 gram of powder.
- The daily amount used in the anti-adhesion research, and accepted by French and European regulators for an anti-adherence statement, is 36 mg of PACs.
- 36 mg divided by 100 mg per gram = 0.36 g. So 360 mg of our powder delivers 36 mg of PACs.
- Our smallest size is 36 g. At 360 mg a day, that is exactly 100 days.
In practice a level quarter-teaspoon of a fine powder is roughly half a gram to a gram, depending on how it packs, so a quarter-teaspoon comfortably clears 36 mg of PACs. If you would rather be precise than approximate, a kitchen scale that reads to 0.1 g costs very little and removes the guesswork entirely.
## Why we sell it as a powder
Powder lets you see and weigh what you are taking, and it lets formulators and home encapsulators build to a target PAC number instead of hoping. It is deep red, genuinely tart, and mixes into water, juice or a smoothie.
## What we will and won't claim
We publish the Certificate of Analysis on the product page, along with third-party heavy-metal testing. We do not present 36 mg of PACs as a Health Canada dose, because it isn't one - Health Canada's monograph is written in fruit and juice equivalents and sets no PAC threshold. We present it as what it is: the figure the mechanism research converged on, which you can now actually calculate for yourself. If a competing product will not state its PAC percentage and will not show you a COA, you cannot run this calculation on their powder - and that, in one sentence, is the difference.
See the product & full COA →Side effects & safety
- Not a treatment for an active infection - seek medical care: Cranberry may help prevent UTIs; it cannot clear one you already have. Burning, urgency, blood in the urine, fever, chills or back pain need a doctor, not a supplement - an untreated bladder infection can reach the kidneys. Health Canada requires licensed products to carry the instruction to ask a practitioner if symptoms persist or worsen.
- Warfarin and other blood thinners: Health Canada requires the warning 'ask a health care practitioner before use if you are taking blood thinners.' The evidence is genuinely conflicting, but MSK's monograph records several case reports of raised INR and two deaths from internal haemorrhage with concurrent warfarin and cranberry juice. Don't self-manage this - speak to whoever monitors your INR.
- Kidney stones and oxalates: Cranberry is high in oxalate and increases urinary oxalate excretion, which can promote the most common type of kidney stone. MSK also notes that its urine-acidifying effect increases uric acid stone risk, and cites a case of recurrent stones in a man taking cranberry concentrate tablets twice daily for six months. Health Canada requires the warning 'ask a health care practitioner before use if you have a history of kidney stones.'
- Aspirin allergy and salicylate sensitivity: Cranberry naturally contains salicylates - the chemical family aspirin belongs to. In a controlled study, two weeks of daily cranberry juice significantly raised salicylic acid in volunteers' urine and plasma, although absorbed amounts stayed low. If you react to aspirin or follow a low-salicylate diet, treat concentrated cranberry with caution.
- Transplant and narrow-margin medications: MSK reports a case of cranberry extract dropping tacrolimus to subtherapeutic levels in a renal transplant patient, resolving on cessation, and notes cranberry inhibits enteric CYP3A and modulates UGT enzymes in laboratory studies. Check with a pharmacist if you take medication with a narrow therapeutic window.
- Pregnancy and breastfeeding: NCCIH notes amounts found in food appear safe but the evidence for larger supplemental amounts isn't conclusive - and the 2023 Cochrane review found no UTI benefit in pregnancy (3 trials, 765 women). Talk to your care provider.
- Digestive upset: Large amounts can cause nausea, vomiting and diarrhoea - MSK cites around three cups of juice daily - and NCCIH notes young children are more susceptible. At sensible extract doses, Cochrane found gastrointestinal side effects probably no different from placebo across 10 trials and 2,166 people.
The bottom line
If you are a woman who keeps getting UTIs, a parent of a child who keeps getting them, or someone facing a bladder procedure, cranberry is one of the better-supported things on the natural-products shelf. Genuinely tested across 50 randomised trials, modestly effective, inexpensive, and safe for most people. Take it every day, give it at least four weeks before judging, aim at roughly 36 mg of PACs, and measure success by counting infections over months - not by how you feel today.
If you are in one of the groups where the trials found nothing - elderly institutional care, pregnancy, a bladder that does not empty properly - the honest advice is to put your money elsewhere and talk to a doctor about what is actually driving the infections.
And if you have a UTI right now - burning, urgency, blood in the urine, fever, chills or back pain - close this page and get medical care today. An untreated bladder infection can climb to the kidneys, and that is a serious illness. Cranberry is a preventive habit. It is not a rescue, and no amount of it should be used to buy time.
References
Every graded claim links to its source; here they are together.
- Urinary tract health: Williams et al., Cochrane Database Syst Rev 2023;11:CD001321
- Urinary tract health (children): Williams et al., Cochrane Database Syst Rev 2023;11:CD001321
- Post-procedure urinary support: Williams et al., Cochrane Database Syst Rev 2023;11:CD001321
- Antioxidant status: Health Canada NHPID Monograph: Cranberry (27 March 2026)
- Mechanism and dosing: ANSES Opinion, Request no. 2010-SA-0214
- Traditional and historical use: NCCIH: Cranberry
- NCCIH: Cranberry
- Cochrane 2023, CD001321
- MSK About Herbs: Cranberry
- Williams et al., Cochrane Database Syst Rev 2023;11:CD001321
- Cochrane 2023, CD001321